Open Menu Open Menu

    St. Thomas Law Review

    Forum

    Administrative LawFDAFeaturedPharmaceuticalsPublic Health

    Treading on Slim Grounds: FDA Flags Unsafe GLP-1 Weight Loss Products

    October 24, 2025By Ciara Maytan

    Ozempic is no longer just a prescription—it has become a cultural phenomenon. From Hollywood red carpets to TikTok feeds, Glucagon-Like Peptide-1 (“GLP-1”) drugs like Ozempic, Wegovy, and Mounjaro are hailed as “miracle” fixes for weight loss. Yet, behind the hype lies an uncomfortable truth: These drugs surged into widespread use quickly, and patients are now […]

    Read More

    Contract LawFeaturedHealth CarePharmaceuticals

    House Blocks Chinese Biotech: Great Wall Built, but Who Guarded the Supply Chain?

    October 21, 2024By Chelsea Barcenas

      On September 9, 2024, the U.S. House of Representatives voted 306-81 in favor of H.R. 8333, known as the Biosecure Act.[i]  The Biosecure Act prohibits U.S. companies from entering into contracts with biotechnology “companies of concern” and their U.S. subsidiaries.[ii] Specifically, the bill blocks partnerships with BGI Group, MGI, WuXi AppTec, WuXi Biologics, and […]

    Read More

    Load Older Posts
    Back to Top